Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Income from Continuing Operations Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Income from Continuing Operations
NT$147.2m
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
48%
G
Grape King Bio Ltd
TWSE:1707
Income from Continuing Operations
NT$2.1B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
5%
Maywufa Co Ltd
TWSE:1731
Income from Continuing Operations
NT$173.2m
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
10%
Chlitina Holding Ltd
TWSE:4137
Income from Continuing Operations
NT$767.2m
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
0%

See Also

What is Maxigen Biotech Inc's Income from Continuing Operations?
Income from Continuing Operations
147.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Income from Continuing Operations amounts to 147.2m TWD.

What is Maxigen Biotech Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
48%

Over the last year, the Income from Continuing Operations growth was -23%. The average annual Income from Continuing Operations growth rates for Maxigen Biotech Inc have been 25% over the past three years , 20% over the past five years , and 48% over the past ten years .

Back to Top